Genome Quebec
7
2
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
Role: collaborator
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
Role: collaborator
Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
Role: collaborator
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
Role: collaborator
Chronic Obstructive Pulmonary Disease Biomarker Study
Role: collaborator
Evaluating an Online Training Program on Shared Decision-making in Prenatal Screening
Role: collaborator
Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
Role: collaborator
All 7 trials loaded